Lister Troy
SEC insider (Form 3/4/5 filer). CIK 0002023489. Chief Scientific Officer at Verve Therapeutics, Inc. (VERV). 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 25, 2025. Located in BOSTON, MA.
Companies Lister Troy has filed insider reports for
- Verve Therapeutics, Inc. (VERV): Officer, Chief Scientific Officer
Lister Troy
CIK: 0002023489
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Verve Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferDirect7K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectRestricted Stock Units
12.1K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectRestricted Stock Units
6.6K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
32K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
69.5K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
225K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectRestricted Stock Units
40K shares- - Apr 2, 2025VERV
Verve Therapeutics, Inc.
SaleDirect2.2K shares at avg. $4.15$9K - Apr 1, 2025VERV
Verve Therapeutics, Inc.
ExerciseDirect7.3K shares- - Jan 8, 2025VERV
Verve Therapeutics, Inc.
AwardDirectStock Option (right to buy)
225K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Tender Offer | 6,952 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Restricted Stock Units | 12,075 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Restricted Stock Units | 6,630 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 32,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 69,500 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 225,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Restricted Stock Units | 40,000 | - | - | Direct |
| Apr 2, 2025 | VERV Verve Therapeutics, Inc. | Sale | 2,189 | $4.15 | $9,084 | Direct |
| Apr 1, 2025 | VERV Verve Therapeutics, Inc. | Exercise | 7,340 | - | - | Direct |
| Jan 8, 2025 | VERV Verve Therapeutics, Inc. | Award Stock Option (right to buy) | 225,000 | - | - | Direct |
1-10 of 11 transactions